Clinical Trial Update: Safety Evaluation of ExAblate MRgFUS for Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of ExAblate MRgFUS for prostate cancer has completed. The document provides a status update on the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Exablate MRgFUS (MR-guided focused ultrasound)

Snippet

Sponsor: InSightec | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED